We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Inspecs Group Plc | SPEC | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -2.00 | -4.08% | 47.00 | 15:25:38 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 49.00 | 47.00 | 49.00 | 47.00 | 49.00 |
| Industry Sector |
|---|
| PERSONAL GOODS |
| Top Posts |
|---|
Posted at 29/1/2024 15:16 by eagle eye The editor at SCSW is a brilliant writer.Can't fault the entertainment value each and every month. Picking the winners and avoiding the losers is down to us. Lots of institutional investors here, so it's not just PI's that have been caught out. |
Posted at 29/1/2024 12:04 by bookbroker Does this vertically integrated model work, this company went on a buying spree in last four years to build an entire design apparatus, so far the results have been derisory, looks like they will be writing down the value of assets if there is no material improvement. Some of these acquisitions have been a waste of time and money, no surprises there, but so far investors have been massively short-changed. |
Posted at 29/1/2024 08:54 by bookbroker Be inclined to agree, if ebitda expected to be £18m for Yr Ending 12/23 then maybe market just crushing the minnows. Efficiencies seem to be ongoing, not sure why Norville still not profitable, and not sure why they continue with the plant unless solely for R&D. I don’t think ebitda a reliable indicator of anything, but that is what accounting standards allow. Maybe this still work in progress, no consolation to investors at the outset! |
Posted at 14/11/2023 08:40 by john09 New thread for sharewatchers. General chat about SCSW followed stocks so investors can discuss 2024 etc. No sharing of subscriber only information |
Posted at 27/10/2023 11:45 by john09 How not to catch a falling knife . This inept less experienced investor bought at 87p and here he is down 20 p in the same montholdboy14 Oct '23 - 10:38 - 956 of 980 cheeky 5k add this morning oldboy1 13 Oct '23 - 09:04 - 958 of 980 added same again this morning. LTH will be rewarded on this one. |
Posted at 29/9/2023 16:20 by seekinvalue Depends on your small cap.But if its going nowhere why haven't IR time.to.answer investor queries. If its not a company engaged with its investor base it doesn't auger well 🤷🏼&# |
Posted at 14/8/2023 11:09 by 74tom @bookbroker, the main issue is a complete lack of UK based institutional investors willing to buy profitable small caps at sensible prices. Shares in Inspecs traded at £3.50 in mid 2022 & one poor quarter decimated the share price. What made it particularly bad was the likes of Aberdeen Asset Management deciding to sell out at the lows as that gave 6% of the company away at a crazy price. I mean WTF was the fund manager doing selling at 40p?But yes, definitely some FOLO going on today, it wouldn't surprise me if someone makes a bid at these levels. |
Posted at 10/7/2023 08:22 by masurenguy Some good progress is being made here to both capitalize on prior acquisitions and also to exploit the post-Covid market in both regular perscription products and sunglasses. There is plenty of scope for a shareprice recovery based upon the prior IPO and subsequent placing some 3 years ago."The Company has successfully raised £23.5m by way of a placing of 12,051,282 new Ordinary Shares with institutional and other investors at a price of 195p per share. In addition, 36,171,506 existing Ordinary Shares have been placed on behalf of Selling Shareholders at the Placing Price, raising gross proceeds of £70.5 m. The Company's market capitalisation on Admission is £138.0m." 27/02/20 "A total of 30,476,191 Placing Shares have been conditionally placed with new and existing investors at a price of 210p per share, representing a nil discount to the mid-market closing price on 18 November 2020. The Placing will raise gross proceeds of approximately £64m and will represent approximately 30.09% of the enlarged issued share capital of the Company following Admission." 19/11/20 "We have had a good performance in Q1 2023 and are ahead of the same period in 2022. This was driven by a rebound in our European markets and continued growth in other markets." 27/04/23. Interims are due in early September. |
Posted at 08/3/2023 11:37 by bookbroker Results should enlighten investors more, after last years shocking collapse I want to see Peck keep a really tight hold on costs and start seeing meaningful progress on generating free cash flow. |
Posted at 28/12/2022 17:52 by darrin1471 I have been taking a closer look at Inspecs and I do have a couple of concerns.Firstly the finance team. 18/08/2022 "We are complementing our finance team with the recruitment of key additional employees to provide greater bandwidth across the Group". If this was not an area of concern then the CEO mentioning it seemed a little odd? 27/10/2022 "Matthew Loran will join the Group as its new Group Finance Manager ... His experience will assist the Group as it continues to expand and integrate its accounting functions. In addition, new accounting personal have been recruited in both the Group's German and USA subsidiaries to enhance reporting and controls." Christopher Kay CFO has been involved with Inspecs since 1988 and finance director since 2013. He does not appear to have any experience outside Inspecs in running an international business. Q3 performance is unbelievably bad 30/06 order book ahead of previous year went to -13% by 30/09 Revenue in H1 in USD was $138.4 vs $125.7 (+$12.7) went to (9 months) $179.4 vs $185(-$5.6) So Q3/22 was $45 vs $59.3 in Q3/21 (nearly -25%) Norville's delays may be a chunk of this but -25% is massive even in current climate. Such a negative Q3 is unlikely to resolve itself soon so the expansion delays appear necessary I will be waiting to see what the full year trading update in January says. I would not be surprised to see more selling at that point as current investors exit and value investors circle. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
